DBS has been FDA-approved for 25 years and is covered by most insurance. But only ~ 0.1% of Parkinson's patients receive it. Jacques Carolan at @ARIA_research is working to close that gap. Full conversation with @JacquesCarolan on the @JuanBenet Podcast >>> https://t.co/v18BHbBYpE